Authors


Harry E. Davis II, MD, MACP

Latest:

Medication-Free Strategies Can Prevent Coronary Heart Disease

Drug therapy is recognized as an effective way to lower lipids and control hypertension, and for its effect on reducing the incidence of myocardial infarction. However, the impact of personal habits, such as eating, drinking, smoking, and exercise, on the incidence of coronary heart disease without reliance on prescription medications and their potential side effects may be less well established.


Steven Roy Daviss, MD

Latest:

National Strategy to Reduce Prescription Drug Abuse

Psychiatrist Steven Roy Daviss, MD provides a detailed review of the elements in the National Drug Control Strategy.


Alexandra Ward, MA

Latest:

Early Momentum for a Genomic Approach to Sickle Cell Disease Therapy

In a late-breaking presentation at ASGCT 2022, investigators shared preclinical results of a gene-editing strategy that seeks to reactivate developmentally silenced fetal hemoglobin (HbF, α2γ2) in order to replace defective sickle hemoglobin (HbS, α2βS2).


Brian Levy, MD

Latest:

Interoperability and Standards: The Effect on Patient Care

As clinicians, we are increasingly accustomed to using EMRs in the hospital, as well as practice management and billing systems in the office.


Audrey Andrews, Freelance Medical Writer

Latest:

BRAF Mutation Emerging as Prognostic in KRAS Wild-Type CRC Patients

Colorectal cancer patients who had wild-type (normal) KRAS gene status, but mutations in the BRAF, had a poor prognosis in spite of treatment with cetuximab.


Nany Tice, MD

Latest:

Get Connected with Online Physician Consultations

How does today’s connected, "always on" world translate to your medical practice?





Mark L. Fuerst

Latest:

CV Risk in Rheumatic Disease

(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.








Salina Graves, MD

Latest:

ADHD Continues to Rise in Children

From 2010 to 2017, there was an increase of over 30% in the number of commercially insured children being diagnosed with ADHD.


By Dinah from Shrink Rap

Latest:

In Treatment: Jesse. Adele. Week 2.

What happened in the latest episode of HBO's In Treatment, and how does it apply to real-life therapy?



Kenneth M. Zangwell, MD

Latest:

How Should I Manage This Man's Pustulovesicular Rash?

A 61 year old male is seen by you for a 3 day history of progressive burning and tingling in the right mid-back area. He reports this morning his wife reports the development of a rash in the area of his symptoms. Examination reveals several grouped pustulovesicular lesions in a right T10 distribution. He denies ever having chickenpox as a child.


RoseMarie Pasmantier, MD, is assistant professor of medicine, Division of Endocrinology, State University of New York Health Sciences Center, Stony Brook, NY.

Latest:

Insulin resistance and heart failure

The prevalence of obesity and heart failure has been increasing. A report linking the 2 found an increased risk of heart failure of 5% for men and 7% for women for each increment of 1 in body mass index (BMI).



Gail Connor Roche

Latest:

Flu Vaccine Stored for Pandemic Risk Found Safe, Immunogenic

The National Pre-Pandemic Influenza Vaccine Stockpile has been storing vaccines for particular pandemic-potential viruses since 2005.






Jared Houck, HIT Squad blogger

Latest:

Why the iPad Will Not Be Used for Healthcare IT

Some health care IT industry heavyweights have gone so far as to suggest that the iPad will be greatly utilized in the healthcare setting and revolutionize the way we do business. While I do think the iPad is incredibly shiny and is great computer replacement for your grandma, I think it's a bit of an exaggeration to suggest that it will ever be fully adopted by healthcare IT shops.



Daniel Weiss

Latest:

Serdaxin Active Ingredient Found to Enhance Neurotransmitter Release

The mechanism of action of clavulanic acid, the active ingredient in Rexahn Pharmaceuticals' Serdaxin, was investigated in a recent study.

© 2024 MJH Life Sciences

All rights reserved.